tirzepatide overdose Mounjaro Injection overdose of tirzepatide CDC Report:

In clinical trials, GLP-1 RAs were shown to significantly lower blood pressure (BP) in addition to HbA1c and body weight (BW), indicating the possibility as anti-hypertensive medication of type 2 DM individuals

Stop use immediately and consult your healthcare provider if you experience any adverse effects

Brief Introduction: Tirzepatide is the worlds first and currently the only glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonist

12.5 mg weekly (50 mg total per vial)

however, there is little information on effects on other pancreatic tissues that might be involved in inflammatory processes

My Diabetes Care Community - Apple Cinnamon Tea